Intramastoid Phosphaturic Mesenchymal Tumor Causing Hypophosphatemic Osteomalacia Detected on Ga-68-DOTATATE PET/CT But Not on Tc-99m-Sestamibi and F-18-FDG Scans

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER HEIDELBERG
Citação
NUCLEAR MEDICINE AND MOLECULAR IMAGING, v.53, n.6, p.436-441, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Ga-68-DOTATATE uptake in mesenchymal tumors causing hypophosphatemic osteomalacia has been recently described. Herein, we present a case of Ga-68-DOTATATE uptake in an intramastoid phosphaturic mesenchymal tumor that had not been depicted in previous Tc-99m-Sestamibi and F-18-FDG scans. The lesion was surgically removed and the phosphorus level increased to the normal range.
Palavras-chave
Hypophosphatemic, Osteomalacia, Mastoid, Gallium-68, DOTA, PET/CT
Referências
  1. Agrawal K, 2015, CLIN NUCL MED, V40, pE6, DOI 10.1097/RLU.0000000000000460
  2. Clifton-Bligh RJ, 2013, J CLIN ENDOCR METAB, V98, P687, DOI 10.1210/jc.2012-3642
  3. de Beur SMJ, 2005, JAMA-J AM MED ASSOC, V294, P1260
  4. Folpe AL, 2004, AM J SURG PATHOL, V28, P1, DOI 10.1097/00000478-200401000-00001
  5. Houang M, 2013, HUM PATHOL, V44, P2711, DOI 10.1016/j.humpath.2013.07.016
  6. Nguyen BD, 1999, CLIN NUCL MED, V24, P130
  7. Paquet M, 2018, EUR J NUCL MED MOL I, V45, P1710, DOI 10.1007/s00259-018-3971-x
  8. Reubi JC, 1996, CANCER RES, V56, P1922
  9. Rhee Y, 2001, CLIN ENDOCRINOL, V54, P551, DOI 10.1046/j.1365-2265.2001.01056.x
  10. WEIDNER N, 1987, CANCER, V59, P1442, DOI 10.1002/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q
  11. WEIDNER N, 1985, CANCER-AM CANCER SOC, V55, P1691, DOI 10.1002/1097-0142(19850415)55:8<1691::AID-CNCR2820550814>3.0.CO;2-S
  12. Zhang JJ, 2015, CLIN NUCL MED, V40, P642, DOI 10.1097/RLU.0000000000000854